24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
pharmaceutical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
08:56
The PC productivity paradox, again
21:03
Nvidia and Microsoft push Washington to protect open AI models
20:36
OpenAI took days to realize its own AI agent breached Hugging Face
20:10
From Mobileye to doubleAI and beyond, Amnon Shashua is preparing for his next act
More stories
Buzz
Most popular
Daily
Weekly
1
Intel expansion uncertainty grows as Israel does not transfer $425 million grant
2
OPPO’s thinnest foldable yet shows the promise, and limits, of the category
3
Israel’s Iron Dome and Arrow makers head toward IPOs, but the listing battle is far from over
4
Wiz’s AI hacker hunter: “I used to hope I found a vulnerability overnight. Today AI tells me it hacked the organization”
5
CyberArk veteran and former IDF cyber chief joins unicorn Upwind
More news
pharmaceutical
4 stories about pharmaceutical
Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million
06.03.19
|
Hagar Ravet
The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
Regulation Hinders Innovative Drug Development in Israel, Executives Say
04.09.17
|
Naomi Zoreff
Despite Israel's advanced medical infrastructure, excessive red tape steers pharmaceutical companies away
Developer Of Anti-Rabies Drug Jumps on FDA Approval
27.08.17
|
Dror Reich
The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus
U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices
21.08.17
|
Dror Reich
Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies